TICKERNOMICS Sign up
Last Update: 2023-12-23 06:01:44
LifeMD Inc. ( LFMD ) https://www.lifemd.com
8.33USD
Sector:
Healthcare
Industry:
Pharmaceutical Retailers
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
LFMD
306.34%
SPY
30.72%
LFMD
14.11%
SPY
112.82%
LFMD
941.25%
SPY
201.04%
LFMD
390.14%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
287.16
293.17
0.91
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-8.32
2.11
-25.91
-6.73
0.00
-21.92
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-11.83
87.62
-9.85
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
5.102
-34.74
-157.90
0.30
Other Earnings and Cash Flow Stats:
LifeMD Inc. ( LFMD ) Net Income TTM ($MM) is -36.22
LifeMD Inc. ( LFMD ) Operating Income TTM ($MM) is -21.10
LifeMD Inc. ( LFMD ) Owners' Earnings Annual ($MM) is 0.00
LifeMD Inc. ( LFMD ) Current Price to Owners' Earnings ratio is 0.00
LifeMD Inc. ( LFMD ) EBITDA TTM ($MM) is -15.71
LifeMD Inc. ( LFMD ) EBITDA Margin is -9.85%
Capital Allocation:
LifeMD Inc. ( LFMD ) has paid 0.00 dividends per share and bought back -3.537261 million shares in the past 12 months
LifeMD Inc. ( LFMD ) has increased its debt by 19.893275 million USD in the last 12 months
Capital Structure:
LifeMD Inc. ( LFMD ) Interest-bearing Debt ($MM) as of last quarter is 21
LifeMD Inc. ( LFMD ) Annual Working Capital Investments ($MM) are -4
LifeMD Inc. ( LFMD ) Book Value ($MM) as of last quarter is -12
LifeMD Inc. ( LFMD ) Debt/Capital as of last quarter is -169%
Other Balance Sheet Stats:
LifeMD Inc. ( LFMD ) has 15 million in cash on hand as of last quarter
LifeMD Inc. ( LFMD ) has 32 million of liabilities due within 12 months, and long term debt 19 as of last quarter
LifeMD Inc. ( LFMD ) has 34 common shares outstanding as of last quarter
LifeMD Inc. ( LFMD ) has 0 million USD of preferred stock value
Academic Scores:
LifeMD Inc. ( LFMD ) Altman Z-Score is -2.33 as of last quarter
LifeMD Inc. ( LFMD ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
LifeMD Inc. ( LFMD ) largest shareholder is Point72 Asset Management, L.P. owning 172203 shares at 1.43 ($MM) value
Bertrand Velge(an insider) Bought 60000 shares of LifeMD Inc. ( LFMD ) for the amount of $235800.00 on 2023-08-31
23.45% of LifeMD Inc. ( LFMD ) is held by insiders, and 17.01% is held by institutions
LifeMD Inc. ( LFMD ) went public on 2001-01-02
Other LifeMD Inc. ( LFMD ) financial metrics:
FCF:-14.51
Unlevered Free Cash Flow:0.00
EPS:-0.71
Operating Margin:-11.83
Gross Profit Margin:87.62
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:193.27
Beta:0.30
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About LifeMD Inc. ( LFMD ) :
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including urgent and primary care, men's and women's health, and dermatology, chronic care management, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, preion medications, patented doctor formulated OTC products, topical compounded medications, and food and drug administration approved medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, preion medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and NavaMD, a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. The company sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.